Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EC FP6 funding directed at device industry:

This article was originally published in Clinica

Executive Summary

Imaging, radiotherapy, clinical trials for breast cancer and leukaemia, and the link between genomics and cancer have been selected by the European Commission among the first group of 19 projects to receive some E100m ($116m) of funding in the context of its Sixth Framework Programme (FP6 2002-2006). The projects will also aim to create bio-banks and cancer registers. A key focus, the Commission says, will be to "quickly turn the advances in cancer research into practical and meaningful early stage diagnoses and therapies for patients". The projects respond to the challenge of creating a European Research Area, according to the Commission, and were chosen to reinforce European excellence and promote research in the fight against cancer.

Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT064011

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel